1. Aguirre FV, Topol EJ, Ferguson JJ, Anderson K, Blankenship JC, Heuser RR, Sigmon K, Taylor M, Gottlieb R, Hanovich G, Rosenberg M, Donohue TJ, Weisman HF, Calif RM (1995) Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients under-going percutaneous coronary intervention. Circulation 91: 2882–2890
2. Albert JP, Regensburger D, Rudolf H (1982) Rezidivprophylaxe operativ korrigierter Arterienverschlüsse der unteren Extremitäten. Med Welt 33: 1829–1831
3. Alike H, Böger RH, Bode-Böger SM (1996) Restenose nach perkutaner transluminaler Angioplastie–Ätiologie und klinische Bedeutung. VASA 25: 13–20
4. Allegra C, Pollari G, Carioti B, Sardina M (1994), Thrombin and platelet inhibition with low dose calcium heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class. Int J Clin Pharmacol Ther32: 646–651
5. Antiplatelet Trialists Collaboration (1994) Collaborative overview of randomised trials of antiplatetel therapy. Br Med J 308; 159–168